Latest News

View All >>

Standing on My Hereditary Cancer Awareness and Prevention Soapbox

June 28th 2022

By Mark Hicks

When participating in FORCE’s Virtual Advocacy Day, it was difficult for me not to go off-script, as anger welled up inside me.

FDA to Speed Up Review of Novel Drug for Mesothelioma Not Treatable by Surgery

June 28th 2022

By Ryan McDonald

The FDA plans to accelerate its review of IK-930, an investigational drug, for the treatment of patients with unresectable NF2-deficient malignant pleural mesothelioma, a rare cancer.

Educated Patient® Metastatic Breast Cancer Summit Supportive Care Presentation: June 11, 2022

June 28th 2022

By Brielle Benyon

Watch Dr. Kimberly Curseen, from Winship Cancer Institute of Emory University, discuss supportive care, during the CURE Educated Patient Metastatic Breast Cancer Summit.

FDA Grants Orphan Drug Designation to Novel CAR-T Cell Therapy to Treat Waldenstrom Macroglobulinemia, a Rare Type of Cancer

June 27th 2022

By Ryan McDonald

Treatment with the novel CAR-T cell therapy was associated with favorable efficacy and safety results in a group of patients with follicular lymphoma, including a few with Waldenstrom macroglobulinemia, according to findings from a study presented at a recent medical conference.

New Resource ‘Empowers’ Patients With Breast Cancer That Has Spread to the Brain With Much Needed Information

June 27th 2022

By Colleen Moretti

Receiving a diagnosis of metastatic breast cancer that has spread to the brain can be a frightening time for patients, however a new resource may help guide them through the stressful journey.